Provided by Tiger Trade Technology Pte. Ltd.

Verastem

5.90
+0.20003.51%
Volume:1.02M
Turnover:6.00M
Market Cap:444.39M
PE:-1.48
High:5.99
Open:5.71
Low:5.67
Close:5.70
52wk High:11.25
52wk Low:4.01
Shares:75.32M
Float Shares:57.38M
Volume Ratio:0.60
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9773
EPS(LYR):-3.6580
ROE:-2888.71%
ROA:-66.06%
PB:-28.62
PE(LYR):-1.61

Loading ...

Verastem Director Michael Kauffman Reports Disposal of Common Shares

Reuters
·
Nov 26, 2025

Verastem Oncology to Present at Evercore Healthcare Conference

Reuters
·
Nov 25, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Molina Healthcare, Memory chip makers, Binah Capital

Reuters
·
Nov 14, 2025

Verastem Oncology Prices $90 Million Offering

MT Newswires Live
·
Nov 14, 2025

BRIEF-Verastem Oncology Prices Public Offering Of 8.5 Million Shares At $7.25 Each

Reuters
·
Nov 14, 2025

Verastem Inc - Prices Public Offering of 8.5 Mln Shares at $7.25 Each

THOMSON REUTERS
·
Nov 14, 2025

Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Nov 14, 2025

Verastem Oncology Shares Down 8.3% After the Bell; Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Nov 14, 2025

BUZZ-Verastem Oncology falls on planned stock offering

Reuters
·
Nov 14, 2025

Verastem Oncology Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Nov 14, 2025

RBC Capital Adjusts Verastem Price Target to $14 From $13, Maintains Outperform Rating

MT Newswires Live
·
Nov 05, 2025

Verastem Oncology to Present at Guggenheim Healthcare Conference

Reuters
·
Nov 05, 2025

H.C. Wainwright Remains a Buy on Verastem (VSTM)

TIPRANKS
·
Nov 05, 2025

Verastem Down Over 20%, on Pace for Largest Percent Decrease Since May 2024 -- Data Talk

Dow Jones
·
Nov 05, 2025

Verastem’s Strong Financial Performance and Strategic Developments Justify Buy Rating Despite Minor Concerns

TIPRANKS
·
Nov 05, 2025

Verastem weakness appears overdone, says Mizuho

TIPRANKS
·
Nov 05, 2025

Stock Track | Verastem Plummets 20.81% as Q3 Net Loss Widens to $98.5 Million Despite Revenue Beat

Stock Track
·
Nov 04, 2025

Stock Track | Verastem Plunges 6.06% Pre-market as Q3 Net Loss Widens Despite Revenue Beat

Stock Track
·
Nov 04, 2025

Stock Track | Verastem Plunges 6% Pre-Market Despite Q3 Revenue Beat as Losses Widen

Stock Track
·
Nov 04, 2025

Verastem Oncology Q3 revenue hits $11.2 mln, net loss widens

Reuters
·
Nov 04, 2025